393 related articles for article (PubMed ID: 32060890)
1. ST2 Signaling in the Tumor Microenvironment.
Chang CP; Hu MH; Hsiao YP; Wang YC
Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
[TBL] [Abstract][Full Text] [Related]
2. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
3. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
Takenaga K; Akimoto M; Koshikawa N; Nagase H
PLoS One; 2020; 15(4):e0232230. PubMed ID: 32340025
[TBL] [Abstract][Full Text] [Related]
4. Role of the IL-33/ST2L axis in colorectal cancer progression.
Akimoto M; Takenaga K
Cell Immunol; 2019 Sep; 343():103740. PubMed ID: 29329638
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
Hong J; Kim S; Lin PC
J Interferon Cytokine Res; 2019 Jan; 39(1):61-71. PubMed ID: 30256696
[TBL] [Abstract][Full Text] [Related]
6. The IL-33/ST2 axis: Role in health and disease.
De la Fuente M; MacDonald TT; Hermoso MA
Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
Ho JE; Chen WY; Chen MH; Larson MG; McCabe EL; Cheng S; Ghorbani A; Coglianese E; Emilsson V; Johnson AD; Walter S; Franceschini N; O'Donnell CJ; ; ; Dehghan A; Lu C; Levy D; Newton-Cheh C; ; Lin H; Felix JF; Schreiter ER; Vasan RS; Januzzi JL; Lee RT; Wang TJ
J Clin Invest; 2013 Oct; 123(10):4208-18. PubMed ID: 23999434
[TBL] [Abstract][Full Text] [Related]
8. Soluble ST2: A complex and diverse role in several diseases.
Homsak E; Gruson D
Clin Chim Acta; 2020 Aug; 507():75-87. PubMed ID: 32305537
[TBL] [Abstract][Full Text] [Related]
9. Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment.
Akimoto M; Maruyama R; Takamaru H; Ochiya T; Takenaga K
Nat Commun; 2016 Nov; 7():13589. PubMed ID: 27882929
[TBL] [Abstract][Full Text] [Related]
10. IL-13 Controls IL-33 Activity through Modulation of ST2.
Zhang M; Duffen JL; Nocka KH; Kasaian MT
J Immunol; 2021 Dec; 207(12):3070-3080. PubMed ID: 34789557
[TBL] [Abstract][Full Text] [Related]
11. Soluble ST2 suppresses IL-5 production by human basophilic KU812 cells, induced by epithelial cell-derived IL-33.
Matsumoto K; Kouzaki H; Kikuoka H; Kato T; Tojima I; Shimizu S; Shimizu T
Allergol Int; 2018 Sep; 67S():S32-S37. PubMed ID: 29941231
[TBL] [Abstract][Full Text] [Related]
12. Soluble ST2--analytical considerations.
Mueller T; Jaffe AS
Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
[TBL] [Abstract][Full Text] [Related]
13. The biology of ST2: the International ST2 Consensus Panel.
Pascual-Figal DA; Januzzi JL
Am J Cardiol; 2015 Apr; 115(7 Suppl):3B-7B. PubMed ID: 25665766
[TBL] [Abstract][Full Text] [Related]
14. IL-33/ST2 as a potential target for tumor immunotherapy.
Jiang W; Lian J; Yue Y; Zhang Y
Eur J Immunol; 2021 Aug; 51(8):1943-1955. PubMed ID: 34131922
[TBL] [Abstract][Full Text] [Related]
15. The Role of IL-33/ST2 Pathway in Tumorigenesis.
Larsen KM; Minaya MK; Vaish V; Peña MMO
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205617
[TBL] [Abstract][Full Text] [Related]
16. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.
Hayakawa H; Hayakawa M; Kume A; Tominaga S
J Biol Chem; 2007 Sep; 282(36):26369-80. PubMed ID: 17623648
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-33 in Malignancies: Friends or Foes?
Shen JX; Liu J; Zhang GJ
Front Immunol; 2018; 9():3051. PubMed ID: 30619376
[TBL] [Abstract][Full Text] [Related]
18. ST2/IL-33 signaling in cardiac fibrosis.
Vianello E; Dozio E; Tacchini L; Frati L; Corsi Romanelli MM
Int J Biochem Cell Biol; 2019 Nov; 116():105619. PubMed ID: 31561019
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia induces downregulation of the tumor-suppressive sST2 in colorectal cancer cells via the HIF-nuclear IL-33-GATA3 pathway.
Akimoto M; Susa T; Okudaira N; Koshikawa N; Hisaki H; Iizuka M; Okinaga H; Takenaga K; Okazaki T; Tamamori-Adachi M
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2218033120. PubMed ID: 37094129
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Production of Soluble ST2 in Heart Failure.
Pascual-Figal DA; Pérez-Martínez MT; Asensio-Lopez MC; Sanchez-Más J; García-García ME; Martinez CM; Lencina M; Jara R; Januzzi JL; Lax A
Circ Heart Fail; 2018 Dec; 11(12):e005488. PubMed ID: 30562096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
